Dr. Miele Cosmed Group Income Statement

Financials in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	504.21	488.35	444.48	396.57	351.87
Revenue Growth (YoY)	3.25%	9.87%	12.08%	12.70%	-3.55%
Cost of Revenue	330.65	278.9	272.98	271.8	218.41
Gross Profit	173.57	209.45	171.5	124.77	133.46
Selling, General & Admin	-	124.98	105.06	94.46	94.93
Other Operating Expenses	143.03	23.56	21.59	17.81	12.71
Operating Expenses	143.03	161.1	138.61	123.6	118.28
Operating Income	30.54	48.36	32.89	1.17	15.17
Interest Expense	-	-5.12	-4.69	-3.72	-1.37
Interest & Investment Income	-	0.28	0.12	0.18	0.12
Currency Exchange Gain (Loss)	-	-0.28	-1.24	0.21	-0.33
Other Non Operating Income (Expenses)	-5.55	-0.14	-0.04	-0.08	-0.21
EBT Excluding Unusual Items	24.99	43.1	27.04	-2.24	13.38
Gain (Loss) on Sale of Assets	-	0.47	0.16	0.37	-0.12
Asset Writedown	-	-0.21	-	-0.23	-
Pretax Income	24.99	43.36	27.2	-2.1	13.26
Income Tax Expense	5.3	7.37	4.98	0.17	1.66
Earnings From Continuing Operations	19.69	35.99	22.22	-2.27	11.6
Net Income to Company	19.69	35.99	22.22	-2.27	11.6
Net Income	19.69	35.99	22.22	-2.27	11.6
Net Income to Common	19.69	35.99	22.22	-2.27	11.6
Net Income Growth	-45.28%	61.97%	-	-	-59.49%
Shares Outstanding (Basic)	86	87	87	87	87
Shares Outstanding (Diluted)	86	87	87	87	87
Shares Change (YoY)	-1.74%	-	-	-	-
EPS (Basic)	0.23	0.41	0.25	-0.03	0.13
EPS (Diluted)	0.23	0.41	0.25	-0.03	0.13
EPS Growth	-44.03%	64.00%	-	-	-60.34%
Free Cash Flow	-	19.14	21.56	-0.75	8.36
Free Cash Flow Per Share	-	0.22	0.25	-0.01	0.10
Dividend Per Share	-	0.100	0.090	-	0.030
Dividend Growth	-	11.11%	-	-	-50.00%
Gross Margin	34.42%	42.89%	38.58%	31.46%	37.93%
Operating Margin	6.06%	9.90%	7.40%	0.29%	4.31%
Profit Margin	3.91%	7.37%	5.00%	-0.57%	3.30%
Free Cash Flow Margin	-	3.92%	4.85%	-0.19%	2.38%
EBITDA	44.66	58.16	42.47	10.69	24.29
EBITDA Margin	8.86%	11.91%	9.55%	2.70%	6.90%
D&A For EBITDA	14.12	9.81	9.58	9.52	9.12
EBIT	30.54	48.36	32.89	1.17	15.17
EBIT Margin	6.06%	9.90%	7.40%	0.29%	4.31%
Effective Tax Rate	21.19%	16.99%	18.30%	-	12.52%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.